Static Chart StemRIM

Stocks

Market Closed - Japan Exchange 09:30:00 06/11/2026 +03			5-day change	1st Jan Change
111.00 ^JPY	-9.76%		-20.14%	-57.79%

10-07	StemRIM Inc. Announces Patent Registration for Stem Cell Gene Therapy Technology SR-GT1 Aimed at Curative Treatment of Dystrophic Epidermolysis Bullosa in USA	CI
09-25	StemRIM Inc. Announces Patent Registration In South Korea For Use Of Redasemtide As Additional Therapeutic Indication Of Cartilage Disorders	CI

Duration

Period